Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera

ropeginterferon
Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera
September 20, 2016
Is a Cure for Blood Cancer Around the Corner?
October 18, 2016

Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera

hearing loss in PV

“Researchers found that the mean hemoglobin and hematocrit levels of the polycythemia vera group were 16.7 g/dL and 50.4%, respectively, vs 13.4 g/dL and 40.3% in control arm. These differences were not statistically significant.”

….these differences look very statistically significant to me! (comment added by MPN-CC)

“Results showed that patients with polycythemia vera had a significantly higher incidence of cochlear impairment compared with controls (P =.004).”

“However, patients with polycythemia vera had significantly higher platelet counts compared with controls (P <.001). Further, nearly three-fourths of those with the myeloproliferative disorder and cochlear involvement had a platelet count greater than 394,000/mm3 (P =.005), suggesting a significant association between platelet count and hearing impairment in this population.”

  • NOTE:  Please read the complete article by clicking on the article box above or here.

 

Comments are closed.

WordPress Security